Long term license agreement

Sensocure AS, Horten and ExoStat Medical, Inc., Prior Lake, Minnesota, has made an agreement on a long-term technology license agreement relating to an electronic sensor that measures partial pressure COs (pCO2) in oral mucosal tissue. The sensor will constitute an essential component of a new non-invasive device developed to measure tissue hypoperfusion and the possible onset of sepsis (“blood poisoning”). Sepsis is a medical condition that claims millions of lives each year, represents enormous medical expense, and is presently the 10th most frequent cause of death in the U.S. The sensor is part of the MicroStat System and will be owned by ExoStat.

Exostat pressrelease in English

Sensocure pressrelease in Norwegian

Fremtidens medisinske produksjonsteknologi

Sensocure, Medistim og GE Vingmed Ultrasound har fått innvilget prosjektstøtte fra programmet BIA Helse hos Norges forskningsråd. Prosjektet er ett av tre prosjekter som har nådd frem i konkurransen om støtte, med prosjektet «Advanced Manufacturing Technologies for...

read more

Multisense

April 2017: Sensocure won a regional research grant from «Oslofjordfondet» for its Multisense project. The subject of research in this project is integration of sensors for real-time and remote measurement of vital signs, including PCO2. Such sensors have the...

read more

Research Position

Sensocure AS is a company with major ambitions in the development and delivery of sensors for medical use. New medical technology developed in the company will be a breakthrough in real-time monitoring of body functions and early detection of organ damage. Sensocure...

read more

Official opening of Verify the solution and Sensocure

On Thursday 2nd of February, Verify the solution and Sensocure proudly had their official opening of the new facilities at Langmyra 11B, Skoppum. More than 90 people from local micro- and nano technology enterprises, SIVA, Innovation Norway, Electronic Coast, students...

read more

Prime Minister Erna Solberg at Sensocure

On the 24th of January 2017 Sensocure was honored with a visit by Prime minister Erna Solberg during her red ribbon opening of Verify the solution AS. In addition to people from Verify and Sensocure, about 30 executives, entrepreneurs and students were present. The...

read more

New location

On January 1st 2017 Sensocure moved into its new facilities at Skoppum. The facility is in a new building of approximately 1000 square meters constituting a new wing of Langmyra 11. Here we can continue developing our product in a 300 square meters’ cleanroom class 6,...

read more

The Nano2021 program

17. Feb 2015: The Nano2021 program has allocated funding for six projects after the announcement of funds with deadline 15.10.2014. In total 54,8 million NOK was distributed. Sensocure was one of the six projects that reached up with a research project entitled...

read more

Pre-projects IscAlert™

27. Jan 2014: Sensocure is about to start the main project for calibration and user interface for IscAlert™, funded by Oslofjordfondet. In collaboration with Oslo University Hospital, Buskerud and Vestfold University College, MicroTech Innovation, Eker Design and...

read more

Financed pre-projects

24. Oct 2013: Since June 2013 Sensocure has been running two pre-projects financed by Oslofjordfondet on concepts for calibration and user interface for the IscAlert™ sensor.  Further research and development is being carried out to develop the concept. The results of...

read more

Sensocure AS

Sensocure AS develops biomedical
sensors for healthcare. The main product
under development is IscAlert™, a CO2
sensor designed for the earliest possible
detection of ischemia.

Press and public relations

Fremtidens medisinske produksjonsteknologi

Sensocure, Medistim og GE Vingmed Ultrasound har fått innvilget prosjektstøtte fra programmet BIA Helse hos Norges forskningsråd. Prosjektet er ett av tre prosjekter som har nådd frem i konkurransen om støtte, med prosjektet «Advanced Manufacturing Technologies for...

Multisense

April 2017: Sensocure won a regional research grant from «Oslofjordfondet» for its Multisense project. The subject of research in this project is integration of sensors for real-time and remote measurement of vital signs, including PCO2. Such sensors have the...

Research Position

Sensocure AS is a company with major ambitions in the development and delivery of sensors for medical use. New medical technology developed in the company will be a breakthrough in real-time monitoring of body functions and early detection of organ damage. Sensocure...